SEGAL LLOYD MITCHELL (President and CEO) received a stock award from REPARE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/6/2025ACC: 0001415889-25-007239
Officer· President and CEO
Since Jun 2020
+277K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
277K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+40K
Price / share
—
Trade value
—
% of position
37.9%
3/4/2025
105.57K→145.57K
Total
Net shares
+40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/4/2025 | A · Award | +40K | — | — | 37.9% | 105.57K | 145.57K |
| Total | +40K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Shares
237K shares
Shares
+237K
Strike price
1.17
Held after
237K
Exercisable
—
3/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Shares237K shares | 3/4/2025 | A · Award | +237K | 1.17 | — | 237K |
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned107.56K
Total
107.56K indirect107.56K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 107.56K | Indirect |
| Total | 107.56K | 107.56K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported